Skip to content
sellWeak cluster of 610b5-1 plan

Moshkevich Solomon sold $809k of NTRA

PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc.. 4,858 shares at an average of $166.59, traded Dec 9, 2024, filed Dec 11, 2024.

Warning score
22
Value
$809k
4,858 shares
Holdings after
114,912
-4% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001415889-24-029036, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 9, 2024AGrant or award
Common Stock10b5-1
+5,752$7.45$43k116,447Dec 11, 2024
Dec 9, 2024AGrant or award
Common Stock10b5-1
+3,323$12.85$43k119,770Dec 11, 2024
Dec 9, 2024SOpen-market sale
Common Stock10b5-1
-4,858$166.59$809k114,912Dec 11, 2024
Dec 9, 2024MOption exercise
Stock Option (right to buy)derivative10b5-1
-5,752$0.00$00Dec 11, 2024
Dec 9, 2024MOption exercise
Stock Option (right to buy)derivative10b5-1
-3,323$0.00$00Dec 11, 2024

Related signals

Other insiders at Natera, Inc. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
25Weaksell 510b5-1NTRA
Natera, Inc.
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$107k669
31Weaksell 510b5-1NTRA
Natera, Inc.
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$388k2,428
34Weaksell 510b5-1NTRA
Natera, Inc.
Sheena Jonathan
director, other
$953k5,700
40Moderatesell 610b5-1NTRA
Natera, Inc.
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$27M160,000
49Moderatesell 6NTRA
Natera, Inc.
Chapman Rowan E
director
$301k1,767
55Moderatesell 5NTRA
Natera, Inc.
BOTHA ROELOF
director
$15M87,473
35Weaksell 710b5-1NTRA
Natera, Inc.
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$665k4,000
65Notablesell 6NTRA
Natera, Inc.
Marcus Gail Boxer
director
$1.5M9,682
40Moderatesell 510b5-1NTRA
Natera, Inc.
Baynes Roy D.
director
$5.4M37,230
41Moderatesell 510b5-1NTRA
Natera, Inc.
Chapman Steven Leonard
CEO AND PRESIDENT
$692k4,728

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.